Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system ... 2024 — Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies ...

Parkinson’s disease is a chronic and progressive condition affecting the brain and nervous system. It impacts millions of ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

A drug that is commonly used to treat ... The drug may also show promise in the treatment of other neurodegenerative diseases, including Huntington's and Parkinson's. Dementia affects more than ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's ... heart disease, new research shows. Nov. 7 (UPI) -- The U.S. Food and Drug Administration has determined commonly ...

Common Degenerative Brain Disease May Begin to Develop in Middle ... In the future, the discovery may be used in treatment for Parkinson's ...